Designing Impactful Leadership and Talent Management Programs with Strategies for Success

Designing Impactful Leadership and Talent Management Programs with Strategies for Success

Sumek Gopal, Head - Human Resources, India Region, Danaher

Sumek Gopal, Head - Human Resources, India Region, Danaher, in an exclusive interview with India Pharma Outlook, shares his views on the adaptations that Indian organizations are making in their leadership development strategies, metrics and KPIs organizations prioritize to ensure leadership programs, future trends shaping Indian firms leadership cultivation and more. He has extensive experience managing and leading HR Teams across various regions such as APAC, Europe, South America, India and Africa. 

In light of India’s demographic diversity and workforce dynamics, how do you access the current state of leadership and talent management programs in pharmaceuticals, and what trends are influencing them?

One of the significant challenges the pharmaceutical sector faces is the shortage of skilled workforce, mainly in the biopharmaceutical sector. As the number of biologics comes off patent in the upcoming months and quarters, a considerable share of work will come to Indian pharmaceutical companies. However, there is a gap in the talent available to upgrade production productivity and improve the research capabilities within the nation. In the case of large multinational companies that have access to global talent management, knowledge management, and scientific expertise. However, Indian organizations have focused on developing these capabilities organically.

For instance, in multinational companies in India, talent gets access through multiple programs and multiple knowledge-sharing platforms, but for Indian companies, learning has to be done from scratch. Companies usually do that when talent management comes into play in terms of influencing the right decision of who to bring in. So, it is crucial to bring in senior talent who is very experienced and can contribute to upskilling and guiding the workforce. Besides, the talent is available, but the main challenge for life sciences, healthcare, and pharmaceutical firms is whether this talent is ready to be deployed effectively.

What adaptations are Indian organizations making in their leadership development strategies to meet innovation, scalability, and agility demands amid the rapid growth of startups and digital transformation in high-growth sectors?

The confluence of artificial intelligence, public health, and life sciences is seen as an interesting area right now. Indian organizations are adapting their leadership development strategies to primarily expose their senior leadership to what AI can do. AI is new to even the technology world. Indian pharmaceutical companies are bringing it into healthcare and exploring the possibility of what can happen. Hence, it is essential to understand that this is a futuristic activity that organizations are facing today.

For instance, Many large organizations, in fact, when looking back around eight years, when Roche first acquired an AI and data firm, it surprised everyone, asking questions about what was going on. However, now people have understood how far along some companies have progressed in recognizing the potential of AI and digital data in healthcare, mainly in public health. The major change companies are making is exposing their senior leadership teams to the possibilities through artificial intelligence.

Besides, the other change companies are making is bringing AI and digital experts into the organization, either in a consulting or employee format, if they have the resources to do so. AI technology and digital are also becoming part of the induction programs, with a fair amount of literature being developed and shared within the industry and the company.

Companies are adopting the full 70-20-10 model and 70% of the tools, such as regular work collaboration tools like Outlook and Teams, are AI-enabled. The 20% is achieved through development programs, while the remaining 10% is through mentoring and exposing talent to different possibilities of artificial intelligence. Also, some companies are using their family offices to invest in startups or fund them to explore the potential growth which can come out of the digital transformation in healthcare and life sciences.

What specific metrics and KPIs are organizations prioritizing to ensure leadership programs are effective and aligned with the evolving expectations of India’s younger workforce (Gen Z and millennials)?

The specific metrics and KPIs that organizations are prioritizing right now, as observed in multiple forums, involve actively looking at internal talent for leadership roles. However, it is safe to say that firms have not had widespread success in this area. Succession planning as a tool or platform is not something which many companies can add that they have cracked it. But more and more, companies are increasingly recognizing the importance of having enough talent to build their leadership pipeline. People are asking hard questions about the expectations of India’s younger workforce, namely Gen Z and Millennials, who exhibit distinct work behaviors. Generation Z, for example, is looking newer work experiences, projects, faster skill development, and quicker career advancements.

They are less concerned about changing jobs frequently, as they have a wide spectrum of opportunities. In comparison, Millennials, while also looking for growth, tend to follow a more traditional path, with a focus on development, but at a slower pace than Gen Z. Even with these differences, the classical KPIs remain consistent across systems: filling roles internally from the available talent pool, attracting the younger workforce, retaining them in the first year, and monitoring promotion velocity to ensure they are moving fast enough. These metrics may not change, regardless of the generational differences in work behavior.

Amid India’s digital push and rise of remote work, in what ways are leadership programs incorporating digital and virtual learning tools, and what impact does this have on accessibility and scalability?

Most programs have now transitioned to a hybrid model, a trend observed across various organizations. Hybrid programs offer scalability and accessibility, making them an appealing choice for companies. However, this format does come with its challenges. For instance, the assumption that a single instructor could manage a program for 40 participants, as they would for 25, does not hold true in a hybrid setup. To maintain quality, companies must increase the number of facilitators. The rise of remote work is another significant factor that requires more diligent, as its very specific sector. Nearly three years post-COVID, many companies are returning to office-based work. Industries such as commercial R&D and manufacturing had already resumed in-person operations earlier, while remote work remains more prevalent in technology sectors and global capability centers. Despite this shift, hybrid programs have proven to be effective in engaging a broader audience and are expected to stay.

However, the impact of purely virtual or digital self-learning programs, particularly in the Indian context, raises questions. For skill-building initiatives, such programs can be effective for individuals motivated to learn independently. Nevertheless, in areas like leadership and soft skills development, the success of purely virtual or digital tools is limited. Leadership development relies heavily on shared experiences and collaborative learning, which are better facilitated in personal settings. As a result, companies are increasingly recognizing the need to balance hybrid and in-person approaches for optimal outcomes.

Looking ahead, in what ways do you foresee leadership and talent management strategies adapting to increased AI and data analytics use? What future trends will shape Indian companies’ leadership cultivation?

Leadership in Indian companies is now expected to adapt to working with AI, as it is no longer acceptable for leaders to claim a lack of understanding of this technology. While it is difficult to predict how much things will change, the influence of AI on talent management strategies is becoming apparent. Talent development and selection are increasingly being shaped by the need to integrate AI and data analytics into leadership programs. Companies are beginning to explore the inclusion of AI and data skills in their training modules and are actively seeking these capabilities in new hires.

Although it is still early to measure the full impact of AI and data analytics on talent management strategies, certain trends are emerging. Future leadership cultivation in Indian companies will likely focus on skillsets such as data literacy, AI expertise, innovation, biopharma knowledge, and global business experience. Leadership needs are evolving from traditional areas like commercial and digital marketing to encompass large-scale manufacturing, research, innovation, and the integration of AI and digital technologies.

on the deck

Most Viewed

Addressing Antimicrobial Resistance (AMR) Through Collaborative Efforts Fostering a Quality Culture in the Pharmaceutical Industry Advancements in Computer-Aided Drug Design for Pharmaceutical Research Why India is Gaining Popularity for Clinical Trials The Future of Kidney Transplants in India Usage of Conversational AI in the Health Insurance Sector Strategies for India to Reduce Its API Dependence on China Business Impact of USFDA Approvals on Indian Pharma Companies Innovative Strategies for Expanding Access to Life Saving Healthcare Solutions Badhal Village Crisis: How Rapid Diagnostics Could Have Saved Lives Why India is a Hotspot for Biotech Startups? Why Adapting Flexibility in IP Rights will Drive Generics Market Meeting the Challenges of High-Potency API (HPAPI) Production Impact of Human Factors Engineering on Medical Device Safety The Future of Pharma: Embracing Continuous Manufacturing The Role of Orphan Drugs in Treating Rare Diseases Emerging Technologies Shaping the Future of Drug Formulation Strategies for Optimizing Pharmaceutical Supply Chain Efficiency The Future of Medicine: Harnessing the Power of RNA-based Therapeutics AI in Medicine: Unmasking the Myths and Embracing the Transformative Reality Cycle Pharma Acquires Banner Life Sciences WHO's First-ever Global Summit on Traditional Medicine Starts in Gujarat The Importance of Data Integrity in Pharmaceutical Quality Control DCGI in Talks with Stakeholders to Develop a Standardised Web Platform to Assure Drug Quality and Patient Safety Glenmark Pharmaceuticals secures ANDA Nod for 0.03 per cent Tacrolimus Ointment Streamlining Laboratory Operations with a Modern LIMS Healthtech Start-up Suraksha QR Ropes In Actor Murali Sharma as its Brand Ambassador Unlocking the Potential of Pharmacogenomics: Enhancing Drug Safety and Efficacy The Impact of Pharmaceutical Testing on Drug Development India has Identified Three Health Priorities to Strengthen Global Health Infrastructure, says WHO National Health Authority launches 100 Microsites Project to Speed Up Digital Health Adoption India Should Partner with Australia to avail PBS for the Selection, Listing, and Pricing processes of exported drugs, says Sudarshan Jain Zydus Lifesciences India More than Doubles Profit Due to Increased Sales in the US India Triples Organ Donations over Past Decade says Union health minister Mansukh Mandaviya Advent Therapeutics Awarded $3 Million NIH Grant For Novel Neonatal Lung Therapy Three Pharma Marketing Strategies That Drive Sales Novartis Targets India's Rare Disease Market with 17 Clinical Programs UK Health Regulator approves GSK's Vaccine for the common respiratory virus RSV WHO Urges Increased Use Of Recommended Malaria-Fighting Tools Karnataka Budget Offered a Significant Boost to Health & Lifesciences Start-ups with Focus on Infrastructure & Innovation Three High Potential Moonshot Project Areas in Pharma CCI approves Bharat Biotech International-Eastman Exports deal How Biotech is Revolutionizing the Fight Against Cancer LifeCell and HaystackAnalytics ink strategic pact to scale-up TB whole genome sequencing pan-India Mankind Pharma IPO To Open On April 25 With A Price Fixed At Rs 1,026-1,080 Per Share US CDC Approves Second Omicron-Updated COVID Booster For Adults Three Trends that will Impact Pharmaceutical Industry in 2023 ModeX Therapeutics Commences Phase I EBV Vaccine Trial with Merck Designing Impactful Leadership and Talent Management Programs with Strategies for Success Novo Nordisk and Valo Health Partner to develop novel Treatments FOPE Calls for Extended Deadline for Schedule M Compliance Telix Pharma To Acquire ImaginAb to Boost Therapeutics and Innovation Roche Secures US FDA Approval for its Ultra-Sensitive ISH test Rappta Therapeutics and SpringWorks Partner on Molecular Glue Targeting PP2A Taro Pharma To Acquire entire stake in Antibe Therapeutics Innovent Biologics Secures Breakthrough Therapy Designation for IBI343 Emcure Pharma Launches Largest R&D Centre in Ahmedabad Zydus Bags USFDA Nod for Phase II(b) Trial to Optimize Usnoflast Dosage US FDA Approves Amgen's Lumakras-Vectibix Combo for KRAS G12C-Mutated mCRC Glenmark Pharma Unveils generic anticoagulant injectable emulsion Strides Pharma Bags USFDA Nod for OTC Acetaminophen-Ibuprofen Combo Tablets US FDA Lifts Hold on Sanofi's Trial to Make Cialis Available Over-the-Counter Hoth Therapeutics Expands Intellectual Property with New Patents Jaguar Health Starts POC Trial of Crofelemer for Rare Pediatric Disease MVID Pharma and Healthcare Sector Eyes Union Budget 2025 for Innovation Boost How Innovative Drug Formulations are Enhancing Treatment Outcomes Apollo and Mayapada Healthcare Unite to Boost Indonesia's Healthcare Novo Nordisk Reports Positive Phase 1b/2a Results for Amycretin Govt to Extend Schedule M Compliance Deadline for Drug Manufacturers to Dec Lupin Secures US FDA Nod for Ipratropium Bromide Nasal Solution ANDA Granules Pharmaceuticals Secures USFDA Nod for Key Generic Drug Bajaj Healthcare Bags DCGI Nod to Manufacture Pimavanserin API & Formulation Union Budget 2025: Healthcare Gets 9.78% Boost, Allocation Nears 1 Lakh Crore Metropolis & Roche Launch Self-Sampling HPV Test for Cervical Cancer Sigachi Industries Invests $1M in Hyderabad R&D Hub for API Innovation Pharma Testing Market Surges with Rising Demand for Biologics ISTH Releases Clinical Practice Guideline For Haemophilia Treatment Sanofi and Biovac Lead Polio Vaccine Manufacturing Capabilities Sun Pharma and Takeda Ink Pact To Market Gastrointestinal Drug Takeda and Ascentage Pharma Ink Option Agreement For Olverembatinib Enhancing Compliance through Effective Pharmaceutical Regulatory Affairs Strategies India poised to become a Global Hub for Clinical Trials: Exec SCHOTT Pharma Unveils Next-Gen Polymer Syringes for Enhanced Safety GSK's Jemperli Gains EU Nod for First-Line Treatment of Endometrial Cancer Union Health Secretary Urges Stronger Drug Regulations for Quality Control Telangana Govt Inks Landmark Deals to Propel Life Sciences and Job Growth R&D in Indian Pharma: Breakthroughs and Innovations in 2024 Dr. Reddy's Partners with Shanghai Henlius to Develop Cancer Drug Uniphar Expands Global Footprint with Three New Facilities 74th Indian Pharmaceutical Congress 2025 Opens Registrations AGC Pharma Expands HPAPI Capabilities in Barcelona to Meet Growing Demand The Future of Genomic Sequencing: Trends That Will Define the Next Decade Lexaria Bioscience Ethics Review Board Nod to Commence New GLP-1 Study Amitabh Kant Urges India to Focus on Innovation at BioAsia 2025 Government Enhances Research & Integration Initiatives in Unani Medicine Blind & Deaf individuals face Major Barriers to access Medicines: Report C-CAMP and PariSante Campus launched Indo-French Life Sciences Hub Jaguar Health Begins Pediatric Trial for Crofelemer in Short Bowel Syndrome Algiax Pharma Reports Promising Phase 2a Results for AP-325 Govt Bans 34 Antimicrobials for Use in Animals Pharmaceutical Procurement Strategies: How to Optimize Costs Personalized Medicine: Get Tailored Treatment Plans for You Now How to Bridge the Healthcare Gap in Emerging Markets with MedTech The Evolution of In-Vitro Diagnostics: Trends and Future Prospects Needle-Free Injection System: A Game Changer in Less Pain Vaccination How Global Capability Centers are Shaping the Future of Biometrics Building a Successful Pharma Brand in India: The Role of Scientific Communication Unlocking India's Innovation Potential in Pharma The Future of Green Chemistry in API Production Top 10 Pharmaceutical Recruitment Consultants - 2024 | Pharma Outlook Blockchain for Secure Pharmaceutical Supply Chains - 2025 & Beyond Mass Spectrometry in Biomarker Discovery for Early Disease Detection Iconovo and Lonza Team up to Advance Intranasal Biologic with ICOone Nasal Fetal Imaging to Cardiac Diagnosis: The Expanding Role of Ultrasound Balancing Innovation and Affordability in Medical Solutions for India Changing Landscape for LTBI and Syndromic Testing Methodologies How Advanced Training Methods can Enhance Patient Care Balancing Cost Efficiency and Compliance in Pharmaceutical Manufacturing LUB Urges Govt to Scrap Mandatory Lab Testing for Cough Syrup Exports Role of Optical Imaging in Early Cancer Detection and Treatment Hoth Therapeutics Unveils Promising Data for KIT-Targeting Therapy Pharmexcil Engages ASEAN Nations to Boost Pharma Trade Ties Fortis Partners with Teleflex for South Asia UroLift Training Anti-Infectives: How New Research is Shaping Infection Control Building Bridges for Sustainable Growth through Strategic Alliances in Ethical Pharmaceuticals Quality as the Cornerstone of Lab Solutions FDA Approves Roch's NSCLC Diagnostic Linked to Emrelis How Early Detection is Transforming Cancer Treatment in India Ensuring Data Privacy in Pharma World Enhancing Clinical Trial Supply Chain Resilience to Address Global Disruptions in India Cost-Effectiveness of Minimally Invasive Surgery in Outpatient Settings How Organic Synthesis is Accelerating Drug Discovery in Pharma Strategic finance for pharmaceutical innovation and stability Top 10 Teleradiology Service Providers - 2024 | Pharma Outlook Importance of Investing in R&D and Quality for Competitive Advantage in Eye Care Top 10 In Vitro Diagnostics Companies - 2024 | Pharma Outlook Phytopharmaceuticals: Driving Global Herbal Medicine Innovation Gender Gap in Healthcare: Why Women's Health Needs More Research Impact of Modern Technology on the Indian Life Sciences Sector Why Global Pharma Expects CDMOs to Be Ready for Joint Inspections The Role of Customizable Stent Grafts for Treating Complex Anatomies Nutraceuticals vs Pharmaceuticals: Complementary or Alternative in Chronic Disease Management? Top 10 Pharma CDMO Companies In India – 2023 | Pharma Outlook Leaping Towards Global Compliance with Revised Schedule M Meril Concludes TechVentory, Boosts AI-Driven Healthcare Supply Chains 10 Pharma Sector Revolutions in India Standardizing Medicine Labeling and Embracing Digital Transformation Creating a patient-centric healthcare ecosystem for all Biomanufacturing of Enzymes: A Sustainable Approach to Industrial Biotechnology Integrating CSR into HR Practices to Enhance Brand Reputation in Pharma Merck Launches Phase 3 Trial for Promising Dengue Vaccine V181 Breakthrough: Eye-Opening Healthcare Strategies Doctors Swear By on Doctor's Day 2025 Bristol Myers Squibb Reports Strong Phase 3 Results for Deucravacitinib trail Alcon Launches Innovative Daily Lenses Designed for Long-lasting Comfort Apisolex Excipient by Lubrizol Backs Phase I Drug Success FDA Approves Enflonsia to Prevent RSV in Infants with One Dose Biosimilars in India 2025 Market Trends, Growth Forecast & Opportunities How Regulations Are Shaping India's Medical Device Landscape Bharat Biotech Partners with GSK for Shigella Vaccine Development Eli Lilly Obesity Drug Shows 11.5% Weight Loss in 12 Weeks Laborate Pharmaceuticals: Illuminating Pathways Of Quality, Affordability Innovation In Healthcare Sun Pharma Bags CDSCO Approval to Produce Fexuprazan Hydrochloride Tablets The Fusion of Biology, Medicine, Health, and AI Glenmark Gets DCGI Nod to Launch Oncology Drug BRUKINSA in India Kyndryl Partners with Dr Reddys to Automate Global IT Operations How Robotic Assisted Surgery Is Redefining Precision in Kidney Transplants Top 10 Women Disruptors in Asia Pharmaceutical Industry

Editor's Guest

Related Articles


© 2025 India Pharma Outlook. All Rights Reserved.